SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nabil George, Archana Depala, Laith Al Sweedan, Kuntal Chakravarty, A Case of Multicentric Carcinoid in a Patient with Psoriatic Spondyloarthropathy, Case Reports in Rheumatology, 2015, 2015, 1

    CrossRef

  2. 2
    Enrique R. Soriano, Management of Psoriatic Arthritis, Rheumatic Disease Clinics of North America, 2015, 41, 4, 711

    CrossRef

  3. 3
    Jacek Kujawski, Marek K. Bernard, Elżbieta Jodłowska, Kornelia Czaja, Beata Drabińska, On the interactions of leflunomide and teriflunomide within receptor cavity — NMR studies and energy calculations, Journal of Molecular Modeling, 2015, 21, 5

    CrossRef

  4. 4
    Carlo Palazzi, Salvatore D’Angelo, Michele Gilio, Pietro Leccese, Angela Padula, Ignazio Olivieri, Pharmacological therapy of spondyloarthritis, Expert Opinion on Pharmacotherapy, 2015, 16, 10, 1495

    CrossRef

  5. 5
    Constantin Caruntu, Daniel Boda, Georgiana Dumitrascu, Carolina Constantin, Monica Neagu, Proteomics focusing on immune markers in psoriatic arthritis, Biomarkers in Medicine, 2015, 9, 6, 513

    CrossRef

  6. 6
    Suzanne J. Tintle, Alice B. Gottlieb, Psoriatic Arthritis for the Dermatologist, Dermatologic Clinics, 2015, 33, 1, 127

    CrossRef

  7. 7
    Evan L. Siegel, Ana-Maria Orbai, Christopher T. Ritchlin, Targeting extra-articular manifestations in PsA, Current Opinion in Rheumatology, 2015, 27, 2, 111

    CrossRef

  8. 8
    Ignazio Olivieri, Salvatore D'Angelo, Carlo Palazzi, Angela Padula, Advances in the management of psoriatic arthritis, Nature Reviews Rheumatology, 2014, 10, 9, 531

    CrossRef

  9. 9
    Ashley M Hopkins, Catherine E O’Doherty, David JR Foster, Richard N Upton, Susanna M Proudman, Michael D Wiese, Individualization of leflunomide dosing in rheumatoid arthritis patients, Personalized Medicine, 2014, 11, 4, 449

    CrossRef

  10. 10
    Deepak R Jadon, Neil J McHugh, Other seronegative spondyloarthropathies, Medicine, 2014, 42, 5, 257

    CrossRef

  11. 11
    Barry J Sheane, Vinod Chandran, The future of treatment for psoriatic arthritis, International Journal of Clinical Rheumatology, 2014, 9, 1, 59

    CrossRef

  12. You have free access to this content12
    M. Sevrain, A.P. Villani, M. Rouzaud, T. Barnetche, C. Paul, M.-A. Richard, M. Beylot-Barry, D. Jullien, S. Aractingi, F. Aubin, P. Joly, M. Maitre, A. Cantagrel, J.-P. Ortonne, L. Misery, Treatment (biotherapy excluded) of psoriatic arthritis: an appraisal of methodological quality of international guidelines, Journal of the European Academy of Dermatology and Venereology, 2014, 28,
  13. 13
    Renata Baronaite Hansen, Arthur Kavanaugh, Treatment options for psoriatic arthritis, Expert Opinion on Orphan Drugs, 2014, 2, 7, 695

    CrossRef

  14. 14
    Dafna Gladman, Moderate to Severe Psoriasis, Fourth Edition, 2014,

    CrossRef

  15. 15
    Lazaros I. Sakkas, Ioannis Alexiou, Theodora Simopoulou, Marianna Vlychou, Enthesitis in psoriatic arthritis, Seminars in Arthritis and Rheumatism, 2013, 43, 3, 325

    CrossRef

  16. 16
    DoQuyen Huynh, Arthur Kavanaugh, Psoriatic arthritis: current therapy and future directions, Expert Opinion on Pharmacotherapy, 2013, 14, 13, 1755

    CrossRef

  17. 17
    Helen I Keen, Philip G Conaghan, Susan E Tett, Safety evaluation of leflunomide in rheumatoid arthritis, Expert Opinion on Drug Safety, 2013, 12, 4, 581

    CrossRef

  18. 18
    E. Märker-Hermann, Therapie der Psoriasisarthritis, Zeitschrift für Rheumatologie, 2013, 72, 8, 784

    CrossRef